ArticleBMJ open2025
Health-related quality of life and correlation with clinical severity in patients with acne: a cross-sectional study at a single centre in China.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perceived vs. Clinical Acne Severity: Impact on QoL and Treatment Adherence in Male Military Personnel: A Cross-Sectional Study.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe presence of acne can significantly impact patients' health-related quality of life (HRQoL); however, the correlation between patient-reported HRQoL impairment and clinician-evaluated severity has been unclear. The objective of the study was to evaluate HRQoL in patients with different acne severity using generic, dermatology-specific and acne-specific instruments and investigate the correlation between clinical severity and HRQoL.
designData for the cross-sectional survey were extracted from March 2017 to December 2018. The convenient sampling strategy was used to select participants.
settingThe study was conducted at the Department of Dermatology, Qilu Hospital, Shandong University.
participantsA total of 1056 outpatients participated in the survey, and 962 patients were analysed in the study. PRIMARY AND SECONDARY OUTCOME MEASURES: The generic instrument (EuroQol 5-Dimensions 5-Levels, EQ-5D-5L), dermatology-specific instrument (Dermatology Life Quality Index, DLQI) and acne-specific instrument (Cardiff Acne Disability Index, CADI) were administered to assess HRQoL and the Global Acne Grading System was used to measure clinical severity.
resultsThe mean health state utility (HSU) EQ-5D-5L score of 0.96 (SD: 0.06), a total DLQI score of 6.84 (SD: 4.88) and a total CADI score of 5.72 (SD: 2.81). Patients with moderate and severe acne showed greater impairment compared with patients with mild acne, as evidenced by significantly lower HSU scores (-0.017 and -0.066) and higher DLQI (1.457 and 2.043) and CADI scores (0.726 and 1.685). Clinical severity was weakly correlated with HRQoL scores for all acne severities (rs=-0.131 to 0.167).
conclusionsAcne is associated with significant HRQoL impairments, especially in terms of psychosocial functioning. It is very important to incorporate HRQoL assessment into clinical practice in future research, and dermatology-specific and acne-specific HRQoL instruments should be used in combination to assess the health status of acne patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.